Programmed Death-Ligand 1 Expression in a Large Cohort of Pediatric Patients With Solid Tumor and Association With Clinicopathologic Features in Neuroblastoma — Federica Saletta (2017) | RDL Network
Programmed Death-Ligand 1 Expression in a Large Cohort of Pediatric Patients With Solid Tumor and Association With Clinicopathologic Features in Neuroblastoma
Article 2017 en
Authors
FS
Federica Saletta
RV
Ricardo E. Vilain
AG
Aditya Gupta
Abstract
1 min read
In summary, high PD-L1 expression in patients with neuroblastoma may represent an unfavorable prognostic factor associated with a higher risk of cancer relapse. This work proposes PD-L1 immunohistochemical assessment as a novel parameter for identifying patients with an increased likelihood of cancer recurrence.
Rhiannon K. Beckers, Christina Selinger, Ricardo E. Vilain, Jason Madore, James S. Wilmott, Kate Harvey, Anne Holliday, Caroline Cooper, Elizabeth Robbins, David J. Gillett, Catherine Kennedy, Laurence Gluch, Hugh Carmalt, Cindy Mak, Sanjay Warrier, Harriet E. Gee, Charles Chan, Anna McLean, Emily Walker, Catriona M. McNeil, Jane Beith, Alexander Swarbrick, Richard A Scolyer,
Discussion(0)
No comments yet. Be the first to comment.